Article citationsMore>>

Barrett-Lee, P., Casbard, A., Abraham, J., et al. (2014) Oral Ibandronic Acid versus Intravenous Zoledronic Acid in Treatment of Bone Metastases from Breast Cancer: A Randomised, Open Label, Non-Inferiority Phase 3 Trial. Lancet Oncology, 15, 114-114.
https://doi.org/10.1016/S1470-2045(13)70539-4

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top